SCHEMBL7286273

SCHEMBL7286273

[CH2]C(CO[O])(OCC)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL910259 0.76
SCHEMBL8539819 0.71 ALDH1A1 (0.33)
SCHEMBL128926 0.67
SCHEMBL7285343 0.67
SCHEMBL28279495 0.67
SCHEMBL2226243 0.65
SCHEMBL8538285 0.65
SCHEMBL9509371 0.64
SCHEMBL691901 0.64
SCHEMBL28231931 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5508403-A ENHANCES EFFECTS OF ANTITUMOR AGENTS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1996-04-16 US disclosed
EP-0353692-B1 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL IND LTD (JP) 1995-10-04 EP disclosed
EP-0655455-A1 Novel phosporus containing pyridine derivatives NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1995-05-31 EP disclosed
US-5304550-A Synergistic NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1994-04-19 US disclosed
US-5130303-A Pyridine derivative administering NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-07-14 US disclosed
EP-0353692-A2 Drug effect-enhancing agent for antitumor drug NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1990-02-07 EP disclosed